Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA approved the first generics of the direct oral anticoagulant rivaroxaban, the agency announced on Tuesday.
They are made by licensed pharmacies, but not approved or inspected by the FDA. Drug compounding is allowed when drugs are on the FDA's shortage list, or in circumstances when a patient can't take ...
Several rare disease patient populations received their first-ever FDA-approved drug since Rare Disease Day last year, signifying progress in closing treatment gaps for rare disease. Since Rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results